From:  Artificial intelligence and machine learning in cardiovascular medicine: current applications, clinical evidence, and future directions

 FDA-approved AI/ML applications in cardiovascular medicine.

Application categoryDevice/AlgorithmFDA approval dateClinical indicationPerformance metricsClinical impact
ECG interpretation
Arrhythmia detectionApple Watch ECG2018Atrial fibrillation screeningSensitivity: 98.3%, specificity: 99.6%Population screening
LV dysfunctionAI-ECG (Mayo Clinic)2019Left ventricular dysfunction detectionAUC: 0.93, sensitivity: 86.3%Early diagnosis
12-Lead analysisCardiologs ECG Review2017Multi-arrhythmia detectionSensitivity: > 90% for major arrhythmiasAutomated interpretation
Cardiac imaging
EchocardiographyEchoGo Core2020Automated measurements< 2% variability vs. expertWorkflow efficiency
Cardiac CTHeartFlow FFRCT2014Fractional flow reserveDiagnostic accuracy: 84%Non-invasive assessment
Cardiac MRICircle CVI422019Ventricular function analysisInter-observer variability < 5%Standardized analysis
Risk stratification
CAD riskCleerly Plaque Analysis2021Coronary plaque quantificationRisk prediction improvement: 15–20%Precision medicine
Heart failureIBM Watson Health2020HF readmission predictionAUC: 0.82Resource optimization

AI: artificial intelligence; ML: machine learning.